EE156 Budget Impact Analysis of Inotuzumab Ozogamicin for the Treatment of Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia in Colombia
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.459
https://www.valueinhealthjournal.com/article/S1098-3015(23)00559-4/fulltext
Title :
EE156 Budget Impact Analysis of Inotuzumab Ozogamicin for the Treatment of Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia in Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00559-4&doi=10.1016/j.jval.2023.03.459
First page :
Section Title :
Open access? :
No
Section Order :
11842